Mark Peplow in Nature:
Half a decade ago, chemist Mark Levin was a postdoc looking for a visionary project that could change his field. He found inspiration in a set of published wish lists from pharmaceutical-industry scientists who were looking for ways to transform medicinal chemistry1,2. Among their dreams, one concept stood out: the ability to precisely edit a molecule by deleting, adding or swapping single atoms in its core.
This sort of molecular surgery could dramatically speed up drug discovery — and might altogether revolutionize how organic chemists design molecules. One 2018 review called it a ‘moonshot’ concept. Levin was hooked.
Now head of a team at the University of Chicago in Illinois, Levin is among a cadre of chemists pioneering these techniques, aiming to more efficiently forge new drugs, polymers and biological molecules such as peptides. In the past two years, more than 100 papers on the technique — known as skeletal editing — have been published, demonstrating its potential (see ‘Skeletal editing on the rise’). “There’s a tremendous amount of buzz right now around this topic,” says Danielle Schultz, director of discovery-process chemistry at pharmaceutical company Merck in Kenilworth, New Jersey.
More here.